Our research focuses on substance use disorders (SUDs) in pregnancy and substance-exposed newborns. Specifically, we are conducting trials related to pharmacologic treatments for opioid use disorder in pregnancy; cannabis use disorders in pregnancy; placental biomarkers; genetics; pharmacokinetics; fetal alcohol spectrum disorders (FASD); and the long-term childhood outcomes of substance exposure in utero.
Explore All Pediatric Research Programs
Our Team
Contact
- Principal Investigator
Elisha M. Wachman
Elisha.Wachman@bmc.org - Project Manager
Chloe Deflorimonte
Chloe.Deflorimonte@bmc.org
Investigators
Department of Pediatrics
Department of Obstetrics & Gynecology
Research Projects
- Promoting positive parenting for mothers with OUD: Implementation of a video-coaching intervention in pediatrics (NIH 1K23DA061933)
- Boston University Women’s Health Research Affinity Research Collaborative
- Boston University BIRCWH Program (NIH 1K12AR085635)
- NICU Withdrawal Assessment Scale (Gerber Foundation) CTN-0080 Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMS) Randomized Clinical Trial (UG1DA013732), NCT03918850
- MAT-LINK (Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder in Pregnancy)
- POD (Placental Markers of Opioid Use Disorder on Development) Study (R01HD113143)
- The First Year Study: A Prospective Mixed Methods Study of Maternal and Child Well-being and Risk of Relapse in the First Year Postpartum (BU CTSI)
- SAFEST Choice National Learning Collaborative
- American Academy of Pediatrics FASD Toolkit
- Naltrexone for Cannabis Use Disorder in Pregnancy (BU CTSI)